✦ LIBER ✦

A novel peptide, PLAEIDGIELTY, for the targeting of α9β1-integrins

✍ Scribed by Holm Schneider; Richard P. Harbottle; Yasuyuki Yokosaki; Jan Kunde; Dean Sheppard; Charles Coutelle

Book ID: 117109278
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 159 KB
Volume: 429
Category: Article
ISSN: 0014-5793
DOI: 10.1016/s0014-5793(98)00612-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted gene delivery into α9β1-integri

Targeted gene delivery into α9β1-integrin-displaying cells by a synthetic peptide

✍ Holm Schneider; Richard P. Harbottle; Yasuyuki Yokosaki; Philipp Jost; Charles C 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Design of cyclic RKKH peptide-conjugated

Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin α2β1 receptor

✍ Nina Ø. Knudsen; Raymond M. Schiffelers; Lene Jorgensen; Jens Hansen; Sven Frokj 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 573 KB

A Novel Recognition Site on Laminin for

A Novel Recognition Site on Laminin for the α3β1 Integrin

✍ Sugit Pattaramalai; Keith M. Skubitz; Amy P.N. Skubitz 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Improved targeting of the αvβ3integrin b

Improved targeting of the αvβ3integrin by multimerisation of RGD peptides

✍ Ingrid Dijkgraaf; John A. W. Kruijtzer; Shuang Liu; Annemieke C. Soede; Wim J. G 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 179 KB

The α2β1 integrin: A novel collectin/C1q

The α2β1 integrin: A novel collectin/C1q receptor

✍ Mary M. Zutter; Brian T. Edelson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 386 KB

αvβ3 Integrin-targeting of intraperitone

αvβ3 Integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide

✍ Ingrid Dijkgraaf; John A.W. Kruijtzer; Cathelijne Frielink; Frans H.M. Corstens; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB

## Abstract Ovarian cancer is the fourth most common cause of cancer deaths among females in the western world after cancer of the breast, colon and lung. The inability to control the disease within the peritoneal cavity is the major cause of treatment failure in patients with ovarian cancer. The m